Clinical trial data and FDA decisions can cause biotech stocks to pop or drop, and that makes it critical for biotech investors to keep a close eye on Flexion Therapeutics (NASDAQ:FLXN), Keryx Biopharmaceuticals (NASDAQ:KERX), and Zogenix (NASDAQ:ZGNX) All three stocks have important news coming soon that could make or break investors, so let’s take a closer look at what’s at stake for them.
Better pain prevention
Flexion Therapeutics has developed a long-lasting corticosteroid that may significantly improve pain in patients suffering from osteoarthritis of the knee.
